EC–SPE–stripline-NMR analysis of reactive products: A feasibility study.

D. Falck, A.J. Oosthoek-de Vries, A.J. Kolkman, H. Lingeman, M. Honing, S.S. Wijmenga, A.P.M. Kentgens, W.M.A. Niessen

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Flow-through electrochemical conversion (EC) of drug-like molecules was hyphenated to miniaturized nuclear magnetic resonance spectroscopy (NMR) via on-line solid-phase extraction (SPE). After EC of the prominent p38α mitogen-activated protein kinase inhibitor BIRB796 into its reactive products, the SPE step provided preconcentration of the EC products and solvent exchange for NMR analysis. The acquisition of NMR spectra of the mass-limited samples was achieved in a stripline probe with a detection volume of 150 nL offering superior mass sensitivity. This hyphenated EC-SPE-stripline-NMR setup enabled the detection of the reactive products using only minute amounts of substrate. Furthermore, the integration of conversion and detection into one flow setup counteracts incorrect assessments caused by the degradation of reactive products. However, apparent interferences of the NMR magnetic field with the EC, leading to a low product yield, so far demanded relatively long signal averaging. A critical assessment of what is and what is not (yet) possible with this approach is presented, for example in terms of structure elucidation and the estimation of concentrations. Additionally, promising routes for further improvement of EC-SPE-stripline-NMR are discussed. © 2013 Springer-Verlag Berlin Heidelberg.
Original languageEnglish
Pages (from-to)6711-6720
JournalAnalytical and Bioanalytical Chemistry
Volume405
DOIs
Publication statusPublished - 2013

Fingerprint

Feasibility Studies
Nuclear magnetic resonance spectroscopy
Magnetic Resonance Spectroscopy
Solid Phase Extraction
p38 Mitogen-Activated Protein Kinases
Berlin
Magnetic Fields
Protein Kinase Inhibitors
Magnetic fields
Degradation
Molecules
Substrates
Pharmaceutical Preparations

Cite this

Falck, D. ; Oosthoek-de Vries, A.J. ; Kolkman, A.J. ; Lingeman, H. ; Honing, M. ; Wijmenga, S.S. ; Kentgens, A.P.M. ; Niessen, W.M.A. / EC–SPE–stripline-NMR analysis of reactive products: A feasibility study. In: Analytical and Bioanalytical Chemistry. 2013 ; Vol. 405. pp. 6711-6720.
@article{37ec049b0c064160af62aa944a1ac488,
title = "EC–SPE–stripline-NMR analysis of reactive products: A feasibility study.",
abstract = "Flow-through electrochemical conversion (EC) of drug-like molecules was hyphenated to miniaturized nuclear magnetic resonance spectroscopy (NMR) via on-line solid-phase extraction (SPE). After EC of the prominent p38α mitogen-activated protein kinase inhibitor BIRB796 into its reactive products, the SPE step provided preconcentration of the EC products and solvent exchange for NMR analysis. The acquisition of NMR spectra of the mass-limited samples was achieved in a stripline probe with a detection volume of 150 nL offering superior mass sensitivity. This hyphenated EC-SPE-stripline-NMR setup enabled the detection of the reactive products using only minute amounts of substrate. Furthermore, the integration of conversion and detection into one flow setup counteracts incorrect assessments caused by the degradation of reactive products. However, apparent interferences of the NMR magnetic field with the EC, leading to a low product yield, so far demanded relatively long signal averaging. A critical assessment of what is and what is not (yet) possible with this approach is presented, for example in terms of structure elucidation and the estimation of concentrations. Additionally, promising routes for further improvement of EC-SPE-stripline-NMR are discussed. {\circledC} 2013 Springer-Verlag Berlin Heidelberg.",
author = "D. Falck and {Oosthoek-de Vries}, A.J. and A.J. Kolkman and H. Lingeman and M. Honing and S.S. Wijmenga and A.P.M. Kentgens and W.M.A. Niessen",
year = "2013",
doi = "10.1007/s00216-013-7158-9",
language = "English",
volume = "405",
pages = "6711--6720",
journal = "Analytical and Bioanalytical Chemistry",
issn = "1618-2642",
publisher = "Analytical and Bioanalytical Chemistry",

}

EC–SPE–stripline-NMR analysis of reactive products: A feasibility study. / Falck, D.; Oosthoek-de Vries, A.J.; Kolkman, A.J.; Lingeman, H.; Honing, M.; Wijmenga, S.S.; Kentgens, A.P.M.; Niessen, W.M.A.

In: Analytical and Bioanalytical Chemistry, Vol. 405, 2013, p. 6711-6720.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - EC–SPE–stripline-NMR analysis of reactive products: A feasibility study.

AU - Falck, D.

AU - Oosthoek-de Vries, A.J.

AU - Kolkman, A.J.

AU - Lingeman, H.

AU - Honing, M.

AU - Wijmenga, S.S.

AU - Kentgens, A.P.M.

AU - Niessen, W.M.A.

PY - 2013

Y1 - 2013

N2 - Flow-through electrochemical conversion (EC) of drug-like molecules was hyphenated to miniaturized nuclear magnetic resonance spectroscopy (NMR) via on-line solid-phase extraction (SPE). After EC of the prominent p38α mitogen-activated protein kinase inhibitor BIRB796 into its reactive products, the SPE step provided preconcentration of the EC products and solvent exchange for NMR analysis. The acquisition of NMR spectra of the mass-limited samples was achieved in a stripline probe with a detection volume of 150 nL offering superior mass sensitivity. This hyphenated EC-SPE-stripline-NMR setup enabled the detection of the reactive products using only minute amounts of substrate. Furthermore, the integration of conversion and detection into one flow setup counteracts incorrect assessments caused by the degradation of reactive products. However, apparent interferences of the NMR magnetic field with the EC, leading to a low product yield, so far demanded relatively long signal averaging. A critical assessment of what is and what is not (yet) possible with this approach is presented, for example in terms of structure elucidation and the estimation of concentrations. Additionally, promising routes for further improvement of EC-SPE-stripline-NMR are discussed. © 2013 Springer-Verlag Berlin Heidelberg.

AB - Flow-through electrochemical conversion (EC) of drug-like molecules was hyphenated to miniaturized nuclear magnetic resonance spectroscopy (NMR) via on-line solid-phase extraction (SPE). After EC of the prominent p38α mitogen-activated protein kinase inhibitor BIRB796 into its reactive products, the SPE step provided preconcentration of the EC products and solvent exchange for NMR analysis. The acquisition of NMR spectra of the mass-limited samples was achieved in a stripline probe with a detection volume of 150 nL offering superior mass sensitivity. This hyphenated EC-SPE-stripline-NMR setup enabled the detection of the reactive products using only minute amounts of substrate. Furthermore, the integration of conversion and detection into one flow setup counteracts incorrect assessments caused by the degradation of reactive products. However, apparent interferences of the NMR magnetic field with the EC, leading to a low product yield, so far demanded relatively long signal averaging. A critical assessment of what is and what is not (yet) possible with this approach is presented, for example in terms of structure elucidation and the estimation of concentrations. Additionally, promising routes for further improvement of EC-SPE-stripline-NMR are discussed. © 2013 Springer-Verlag Berlin Heidelberg.

U2 - 10.1007/s00216-013-7158-9

DO - 10.1007/s00216-013-7158-9

M3 - Article

VL - 405

SP - 6711

EP - 6720

JO - Analytical and Bioanalytical Chemistry

JF - Analytical and Bioanalytical Chemistry

SN - 1618-2642

ER -